American Oriental Bioengineering Inc (AOBI)

Currency in USD
0.0005
0.0000(0.00%)
Closed·
AOBI Scorecard
Full Analysis
Stock generally trades with low price volatility
Trading near 52-week High
Fair Value
Day's Range
0.00050.0005
52 wk Range
0.00050.0005
Key Statistics
Prev. Close
0.0005
Open
0.0005
Day's Range
0.0005-0.0005
52 wk Range
0.0005-0.0005
Volume
-
Average Volume (3m)
398
1-Year Change
0%
Book Value / Share
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
AOBI Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

American Oriental Bioengineering Inc Company Profile

American Oriental Bioengineering, Inc. engages in the development, manufacture, and commercialization of various pharmaceutical and healthcare products. The company primarily provides prescription pharmaceutical products, including Shuanghuanglian Lyophilized Injection Powder under the SHL brand for the treatment of flu symptoms, such as high fever, cough, and sore throat, as well as upper respiratory infections, mild pneumonia, bronchitis, and tonsillitis; and Cease Enuresis Soft Gel under the CE Gel brand to alleviate bedwetting. It also offers over-the-counter pharmaceutical products comprising Cease Enuresis Patch for the treatment of bedwetting and incontinence; Jinji Capsule for the treatment of endometritis, annexitis, and pelvic inflammations; Jinji Yimucao for the treatment of premenstrual syndrome (PMS) and other PMS and menopause-related symptoms; and Boke Nasal Spray for the treatment of sinus congestion from common cold, stuffy nose, chronic rhinitis, allergic rhinitis, and nasosinusitis. In addition, the company provides various nutraceutical products, such as soybean peptide based drinks, tablets, powder, and instant coffee. Further, it is involved in the wholesale and retail of pharmaceutical and nutraceutical products. The company sells its products directly and through distributors to hospitals, clinics, pharmacies, supermarkets, fitness centers, specialty nutraceutical stores, and other retail outlets in the People’s Republic of China. American Oriental Bioengineering, Inc. is headquartered in Beijing, China.

Employees
3719

Compare AOBI to Peers and Sector

Metrics to compare
AOBI
Peers
Sector
Relationship
P/E Ratio
0.0x−3.5x12.0x
PEG Ratio
0.00−0.010.03
Price/Book
0.0x0.8x1.5x
Price / LTM Sales
0.0x1.3x0.9x
Upside (Analyst Target)
0.0%−37.9%17.9%
Fair Value Upside
Unlock13.8%11.1%Unlock

Earnings

Latest Release
Nov 18, 2024
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

AOBI Income Statement

FAQ

What Stock Exchange Does American Oriental Bioengineering Trade On?

American Oriental Bioengineering is listed and trades on the OTC Markets stock exchange.

What Is the Stock Symbol for American Oriental Bioengineering?

The stock symbol for American Oriental Bioengineering is "AOBI."

What Is the American Oriental Bioengineering Market Cap?

As of today, American Oriental Bioengineering market cap is 36.50.

What Is American Oriental Bioengineering's Earnings Per Share (TTM)?

The American Oriental Bioengineering EPS (TTM) is -1,243.22.

From a Technical Analysis Perspective, Is AOBI a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has American Oriental Bioengineering Stock Split?

American Oriental Bioengineering has split 4 times.

How Many Employees Does American Oriental Bioengineering Have?

American Oriental Bioengineering has 3719 employees.

What is the current trading status of American Oriental Bioengineering (AOBI)?

As of 16 Jul 2025, American Oriental Bioengineering (AOBI) is trading at a price of 0.00, with a previous close of 0.00. The stock has fluctuated within a day range of 0.00 to 0.00, while its 52-week range spans from 0.00 to 0.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.